Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
3.060
-0.090 (-2.86%)
At close: Sep 8, 2025, 4:00 PM
3.070
+0.010 (0.33%)
After-hours: Sep 8, 2025, 4:10 PM EDT

Protara Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
118253213076271
Upgrade
Market Cap Growth
172.97%1089.52%-29.43%-60.18%-72.06%-
Upgrade
Enterprise Value
-24177-47-70-55106
Upgrade
Last Close Price
3.155.281.882.686.7524.21
Upgrade
PB Ratio
0.841.520.310.300.471.36
Upgrade
P/TBV Ratio
0.821.520.310.300.571.60
Upgrade
Debt / Equity Ratio
0.030.030.080.060.050.01
Upgrade
Quick Ratio
12.6115.5410.7114.7821.3757.84
Upgrade
Current Ratio
12.8215.7111.1715.0121.6658.13
Upgrade
Return on Equity (ROE)
-43.02%-37.88%-47.44%-49.96%-26.17%-34.48%
Upgrade
Return on Assets (ROA)
-27.72%-23.59%-28.36%-16.42%-15.80%-21.07%
Upgrade
Return on Capital (ROIC)
-29.21%-25.04%-29.91%-16.91%-16.07%-21.72%
Upgrade
Earnings Yield
-43.08%-17.59%-189.67%-218.41%-62.30%-12.52%
Upgrade
FCF Yield
-37.93%-14.15%-176.45%-88.01%-46.28%-8.95%
Upgrade
Buyback Yield / Dilution
-139.68%-81.73%-0.64%-0.24%-55.28%-180.66%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q